147 related articles for article (PubMed ID: 37481823)
1. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
[TBL] [Abstract][Full Text] [Related]
3. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells.
Löblein MT; Falke I; Eich HT; Greve B; Götte M; Troschel FM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768932
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21
Troschel FM; Palenta H; Borrmann K; Heshe K; Hua SH; Yip GW; Kiesel L; Eich HT; Götte M; Greve B
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3299-3312. PubMed ID: 34291358
[TBL] [Abstract][Full Text] [Related]
5. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.
Sutherland JM; Fraser BA; Sobinoff AP; Pye VJ; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
Biol Reprod; 2014 May; 90(5):92. PubMed ID: 24671879
[TBL] [Abstract][Full Text] [Related]
8. The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice.
Sundar J; Matalkah F; Jeong B; Stoilov P; Ramamurthy V
J Biol Chem; 2021; 296():100048. PubMed ID: 33168629
[TBL] [Abstract][Full Text] [Related]
9. Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis.
Strauß T; Greve B; Gabriel M; Achmad N; Schwan D; Espinoza-Sanchez NA; Laganà AS; Kiesel L; Poutanen M; Götte M; Schäfer SD
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269992
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation.
Falke I; Troschel FM; Palenta H; Löblein MT; Brüggemann K; Borrmann K; Eich HT; Götte M; Greve B
Stem Cell Res Ther; 2022 May; 13(1):212. PubMed ID: 35619161
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.
Sureban SM; May R; George RJ; Dieckgraefe BK; McLeod HL; Ramalingam S; Bishnupuri KS; Natarajan G; Anant S; Houchen CW
Gastroenterology; 2008 May; 134(5):1448-58. PubMed ID: 18471519
[TBL] [Abstract][Full Text] [Related]
13. Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue.
Talebi-Yazdabadi Z; Jahanbakhsh N; Dormiani K; Forouzanfar M; Lachinani L; Zohrabi D; Tavalaee M; Nasr-Esfahani MH
Andrologia; 2021 Nov; 53(10):e14187. PubMed ID: 34309875
[TBL] [Abstract][Full Text] [Related]
14. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
15. The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity.
Siddall NA; McLaughlin EA; Marriner NL; Hime GR
Proc Natl Acad Sci U S A; 2006 May; 103(22):8402-7. PubMed ID: 16717192
[TBL] [Abstract][Full Text] [Related]
16. Musashi expression in β-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetes.
Szabat M; Kalynyak TB; Lim GE; Chu KY; Yang YH; Asadi A; Gage BK; Ao Z; Warnock GL; Piret JM; Kieffer TJ; Johnson JD
Cell Death Dis; 2011 Nov; 2(11):e232. PubMed ID: 22113197
[TBL] [Abstract][Full Text] [Related]
17. (-)- Gossypol Inhibition of Musashi-Mediated Forgetting Improves Memory and Age-Dependent Memory Decline in Caenorhabditis elegans.
Mastrandreas P; Arnold A; Boglari C; de Quervain DJ; Stetak A; Papassotiropoulos A
Mol Neurobiol; 2023 Feb; 60(2):820-835. PubMed ID: 36378468
[TBL] [Abstract][Full Text] [Related]
18. Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.
Lan L; Xing M; Kashipathy M; Douglas J; Gao P; Battaile K; Hanzlik R; Lovell S; Xu L
Proteins; 2020 Apr; 88(4):573-583. PubMed ID: 31603583
[TBL] [Abstract][Full Text] [Related]
19. Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein.
Darai N; Mahalapbutr P; Wolschann P; Lee VS; Wolfinger MT; Rungrotmongkol T
Sci Rep; 2022 Jul; 12(1):12137. PubMed ID: 35840700
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
